Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Cocrystal Pharma
Company

Cocrystal Pharma

Tracked across 2 events · 12 articles · First seen Apr 02, 2026 · Last active Aug 17, 2026

Sentiment
42
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 75
Regulatory
FDA Fast Track for Cocrystal Pharma's CDI-988
Impact: Cocrystal Pharma received Fast Track designation from the FDA for its oral antiviral candidate, CDI-988, for norovirus infection, which is a significant milestone for the company and led to a substantial jump in its stock price.
Apr 02, 2026 · 6 articles
1 10
Business
Cocrystal Pharma Appoints Carol Brosgart to Board
Cocrystal Pharma, Inc., a clinical-stage biotechnology company developing antiviral therapeutics, announced the appointment of Carol Brosgart, MD to its Board of Directors, effective August 12, 2026. Dr. Brosgart brings decades of experience in antiviral therapy,…
Impact: Cocrystal Pharma appointed Carol Brosgart to its board, gaining her expertise in antiviral drug development as it advances its pipeline, including CDI-988 for norovirus.
Aug 17, 2026 · 6 articles
Key Actions (1)
100 Cocrystal Pharma appointed Carol BrosgartCocrystal Pharma Appoints...
ERGEN INTELLIGENCE
Track Cocrystal Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.